Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Migraine Disorders | 128 | 2024 | 1693 | 15.650 |
Why?
|
Botulinum Toxins, Type A | 16 | 2024 | 229 | 7.180 |
Why?
|
Cortical Spreading Depression | 17 | 2024 | 288 | 7.020 |
Why?
|
Nociceptors | 32 | 2024 | 457 | 6.210 |
Why?
|
Photophobia | 11 | 2019 | 71 | 4.300 |
Why?
|
Trigeminal Nerve | 16 | 2024 | 248 | 3.970 |
Why?
|
Calcitonin Gene-Related Peptide | 13 | 2022 | 314 | 3.460 |
Why?
|
Headache | 20 | 2024 | 1249 | 3.310 |
Why?
|
Neuromuscular Agents | 9 | 2024 | 148 | 3.200 |
Why?
|
Headache Disorders | 7 | 2024 | 148 | 2.780 |
Why?
|
Rats, Sprague-Dawley | 47 | 2024 | 8158 | 2.750 |
Why?
|
Hyperalgesia | 14 | 2023 | 530 | 2.640 |
Why?
|
Dura Mater | 14 | 2024 | 290 | 2.610 |
Why?
|
Meninges | 11 | 2020 | 197 | 2.550 |
Why?
|
Thalamus | 10 | 2021 | 1041 | 1.880 |
Why?
|
Serotonin Receptor Agonists | 8 | 2009 | 151 | 1.800 |
Why?
|
Cerebral Arteries | 5 | 2019 | 493 | 1.740 |
Why?
|
Hypothalamus | 12 | 2019 | 998 | 1.630 |
Why?
|
Neurons | 23 | 2024 | 9424 | 1.560 |
Why?
|
Trigeminal Nucleus, Spinal | 5 | 2024 | 21 | 1.470 |
Why?
|
Antibodies, Monoclonal | 11 | 2023 | 9185 | 1.460 |
Why?
|
Rats | 50 | 2024 | 23709 | 1.460 |
Why?
|
Sumatriptan | 9 | 2022 | 66 | 1.460 |
Why?
|
Neurotransmitter Agents | 4 | 2020 | 663 | 1.330 |
Why?
|
Nerve Fibers, Unmyelinated | 5 | 2022 | 97 | 1.280 |
Why?
|
Pain | 20 | 2022 | 5066 | 1.260 |
Why?
|
Trigeminal Ganglion | 10 | 2013 | 190 | 1.190 |
Why?
|
Neural Pathways | 18 | 2021 | 3040 | 1.170 |
Why?
|
Light | 5 | 2018 | 1344 | 1.050 |
Why?
|
Post-Traumatic Headache | 5 | 2024 | 65 | 1.030 |
Why?
|
Visual Cortex | 4 | 2020 | 1089 | 1.000 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2017 | 364 | 0.970 |
Why?
|
Neuropeptides | 3 | 2020 | 943 | 0.940 |
Why?
|
Visual Pathways | 3 | 2018 | 534 | 0.930 |
Why?
|
Pain Measurement | 22 | 2017 | 3527 | 0.900 |
Why?
|
Brain Stem | 7 | 2019 | 857 | 0.870 |
Why?
|
Physical Stimulation | 13 | 2017 | 518 | 0.830 |
Why?
|
Vasodilation | 3 | 2019 | 962 | 0.830 |
Why?
|
Tension-Type Headache | 4 | 2024 | 76 | 0.810 |
Why?
|
Spinal Nerves | 2 | 2019 | 91 | 0.780 |
Why?
|
Urinary Bladder, Overactive | 1 | 2023 | 114 | 0.770 |
Why?
|
Neck Pain | 4 | 2023 | 186 | 0.770 |
Why?
|
Naproxen | 3 | 2019 | 100 | 0.740 |
Why?
|
Animals | 73 | 2024 | 167960 | 0.730 |
Why?
|
Sensory Receptor Cells | 6 | 2012 | 509 | 0.720 |
Why?
|
Pain Threshold | 14 | 2023 | 603 | 0.720 |
Why?
|
Tryptamines | 6 | 2022 | 93 | 0.710 |
Why?
|
SNARE Proteins | 1 | 2020 | 80 | 0.710 |
Why?
|
Ganglia, Sensory | 1 | 2019 | 19 | 0.700 |
Why?
|
Brain | 20 | 2021 | 26951 | 0.690 |
Why?
|
Ganglia, Autonomic | 1 | 2019 | 43 | 0.690 |
Why?
|
Retina | 5 | 2019 | 2635 | 0.670 |
Why?
|
Blood-Brain Barrier | 3 | 2021 | 1019 | 0.670 |
Why?
|
Afferent Pathways | 7 | 2013 | 299 | 0.640 |
Why?
|
Cerebral Cortex | 13 | 2020 | 5761 | 0.640 |
Why?
|
Migraine with Aura | 2 | 2019 | 203 | 0.630 |
Why?
|
Trigeminal Nuclei | 6 | 2011 | 39 | 0.620 |
Why?
|
Pia Mater | 2 | 2018 | 87 | 0.610 |
Why?
|
Action Potentials | 9 | 2013 | 1816 | 0.610 |
Why?
|
Electroretinography | 2 | 2019 | 517 | 0.610 |
Why?
|
Retinal Cone Photoreceptor Cells | 2 | 2016 | 180 | 0.600 |
Why?
|
Dark Adaptation | 1 | 2019 | 221 | 0.600 |
Why?
|
Central Nervous System | 5 | 2020 | 1334 | 0.600 |
Why?
|
Nerve Compression Syndromes | 1 | 2019 | 160 | 0.590 |
Why?
|
Color Perception | 1 | 2018 | 212 | 0.580 |
Why?
|
Retinal Ganglion Cells | 3 | 2019 | 805 | 0.580 |
Why?
|
Evoked Potentials, Visual | 2 | 2019 | 415 | 0.580 |
Why?
|
Glutamic Acid | 2 | 2020 | 1167 | 0.570 |
Why?
|
Occipital Lobe | 1 | 2018 | 373 | 0.550 |
Why?
|
Diclofenac | 1 | 2017 | 67 | 0.550 |
Why?
|
Peripheral Nervous System | 3 | 2020 | 151 | 0.530 |
Why?
|
Male | 99 | 2024 | 359718 | 0.530 |
Why?
|
Ganglia, Spinal | 1 | 2019 | 523 | 0.530 |
Why?
|
Nerve Net | 7 | 2020 | 2261 | 0.530 |
Why?
|
Pupil | 1 | 2016 | 141 | 0.520 |
Why?
|
Synaptic Transmission | 3 | 2017 | 1171 | 0.520 |
Why?
|
Neuralgia | 1 | 2022 | 599 | 0.520 |
Why?
|
Extracellular Fluid | 1 | 2017 | 165 | 0.510 |
Why?
|
Cerebral Veins | 1 | 2017 | 157 | 0.510 |
Why?
|
Periosteum | 1 | 2016 | 138 | 0.510 |
Why?
|
Neurotoxins | 2 | 2014 | 240 | 0.510 |
Why?
|
Trigeminal Caudal Nucleus | 3 | 2011 | 18 | 0.500 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2020 | 952 | 0.500 |
Why?
|
Immunologic Factors | 3 | 2020 | 1588 | 0.500 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 3 | 2024 | 31 | 0.470 |
Why?
|
Models, Neurological | 5 | 2017 | 1758 | 0.450 |
Why?
|
Fluorescent Dyes | 4 | 2019 | 1913 | 0.440 |
Why?
|
Myelin Sheath | 1 | 2017 | 651 | 0.440 |
Why?
|
Brain Mapping | 16 | 2021 | 6569 | 0.440 |
Why?
|
Humans | 119 | 2024 | 760613 | 0.440 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 1501 | 0.440 |
Why?
|
Decompression, Surgical | 1 | 2018 | 604 | 0.430 |
Why?
|
Spinal Cord | 6 | 2020 | 1817 | 0.430 |
Why?
|
Simvastatin | 1 | 2015 | 352 | 0.430 |
Why?
|
Somatosensory Cortex | 4 | 2018 | 511 | 0.420 |
Why?
|
Phenylenediamines | 1 | 2013 | 86 | 0.420 |
Why?
|
Posterior Horn Cells | 3 | 2011 | 90 | 0.390 |
Why?
|
Carbamates | 1 | 2013 | 192 | 0.390 |
Why?
|
Arteries | 2 | 2020 | 1126 | 0.380 |
Why?
|
Spiro Compounds | 2 | 2022 | 68 | 0.380 |
Why?
|
Medulla Oblongata | 3 | 2000 | 248 | 0.380 |
Why?
|
Drug Labeling | 1 | 2014 | 251 | 0.380 |
Why?
|
Thalamic Nuclei | 1 | 2011 | 111 | 0.380 |
Why?
|
Pons | 1 | 2012 | 239 | 0.380 |
Why?
|
Skin | 11 | 2017 | 4466 | 0.370 |
Why?
|
Epilepsy | 2 | 2024 | 3267 | 0.370 |
Why?
|
Cholecalciferol | 1 | 2015 | 550 | 0.360 |
Why?
|
Mandibular Nerve | 1 | 2010 | 59 | 0.350 |
Why?
|
Migraine without Aura | 1 | 2011 | 82 | 0.350 |
Why?
|
Female | 68 | 2024 | 391246 | 0.350 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3332 | 0.350 |
Why?
|
Stimulation, Chemical | 5 | 2013 | 306 | 0.340 |
Why?
|
Treatment Outcome | 22 | 2023 | 64981 | 0.330 |
Why?
|
Pain, Intractable | 1 | 2010 | 132 | 0.330 |
Why?
|
Limbic System | 4 | 2009 | 419 | 0.320 |
Why?
|
Electrophysiology | 8 | 2014 | 1265 | 0.320 |
Why?
|
Parasympathetic Nervous System | 3 | 2009 | 141 | 0.310 |
Why?
|
Double-Blind Method | 12 | 2024 | 12427 | 0.300 |
Why?
|
Psychophysics | 2 | 2019 | 289 | 0.300 |
Why?
|
Stilbamidines | 3 | 2013 | 43 | 0.300 |
Why?
|
Adult | 54 | 2024 | 220007 | 0.290 |
Why?
|
Vasoconstrictor Agents | 1 | 2011 | 651 | 0.290 |
Why?
|
Seizures | 1 | 2020 | 2917 | 0.290 |
Why?
|
Photic Stimulation | 3 | 2019 | 1967 | 0.290 |
Why?
|
Evoked Potentials | 2 | 2012 | 1036 | 0.280 |
Why?
|
Ketorolac | 2 | 2020 | 94 | 0.280 |
Why?
|
Dendritic Cells | 1 | 2018 | 2725 | 0.280 |
Why?
|
Color | 2 | 2018 | 298 | 0.270 |
Why?
|
Neurons, Afferent | 3 | 1998 | 498 | 0.270 |
Why?
|
Nerve Block | 4 | 2020 | 688 | 0.260 |
Why?
|
Analgesics | 5 | 2024 | 1065 | 0.260 |
Why?
|
Blindness | 3 | 2018 | 582 | 0.250 |
Why?
|
Histamine | 3 | 2014 | 498 | 0.250 |
Why?
|
TRPV Cation Channels | 2 | 2018 | 243 | 0.250 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2017 | 2282 | 0.250 |
Why?
|
Behavior, Animal | 1 | 2013 | 1866 | 0.250 |
Why?
|
Middle Aged | 43 | 2024 | 220359 | 0.240 |
Why?
|
Cross-Over Studies | 3 | 2024 | 2061 | 0.240 |
Why?
|
Pyrroles | 2 | 2022 | 1137 | 0.240 |
Why?
|
Young Adult | 23 | 2024 | 58748 | 0.240 |
Why?
|
Rod Opsins | 2 | 2018 | 108 | 0.240 |
Why?
|
Skull | 1 | 2009 | 815 | 0.240 |
Why?
|
Piperidines | 3 | 2022 | 1650 | 0.230 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 613 | 0.230 |
Why?
|
Inflammation | 5 | 2022 | 10755 | 0.220 |
Why?
|
Infusions, Intravenous | 3 | 2019 | 2235 | 0.220 |
Why?
|
Macrophages | 2 | 2018 | 5745 | 0.220 |
Why?
|
Autonomic Nervous System | 2 | 2019 | 697 | 0.220 |
Why?
|
Anticonvulsants | 1 | 2013 | 1879 | 0.210 |
Why?
|
Lidocaine | 3 | 2020 | 538 | 0.210 |
Why?
|
Sleep | 2 | 2019 | 4750 | 0.210 |
Why?
|
Adolescent | 21 | 2024 | 87809 | 0.210 |
Why?
|
Serotonin | 3 | 2014 | 1040 | 0.200 |
Why?
|
Receptors, Cholecystokinin | 1 | 2001 | 18 | 0.200 |
Why?
|
Pyridines | 4 | 2022 | 2879 | 0.200 |
Why?
|
Brain Chemistry | 2 | 2019 | 959 | 0.200 |
Why?
|
Africa South of the Sahara | 1 | 2024 | 742 | 0.190 |
Why?
|
Ventromedial Hypothalamic Nucleus | 1 | 2001 | 46 | 0.190 |
Why?
|
Cardiovascular System | 2 | 2019 | 850 | 0.190 |
Why?
|
Microelectrodes | 2 | 2014 | 304 | 0.190 |
Why?
|
Cholecystokinin | 1 | 2001 | 117 | 0.190 |
Why?
|
Acetylcholine | 1 | 2023 | 629 | 0.190 |
Why?
|
Face | 3 | 2010 | 1017 | 0.180 |
Why?
|
Cerebrovascular Circulation | 4 | 2017 | 2733 | 0.180 |
Why?
|
Anorexia | 1 | 2001 | 154 | 0.180 |
Why?
|
Anxiety | 2 | 2021 | 4538 | 0.180 |
Why?
|
Vitamin D | 1 | 2014 | 3291 | 0.180 |
Why?
|
Reticular Formation | 1 | 2000 | 59 | 0.180 |
Why?
|
Disease Models, Animal | 7 | 2017 | 18137 | 0.180 |
Why?
|
Somatosensory Disorders | 1 | 2000 | 49 | 0.170 |
Why?
|
Vasodilator Agents | 2 | 2005 | 978 | 0.170 |
Why?
|
Dopamine | 2 | 2019 | 1595 | 0.170 |
Why?
|
Cyclooxygenase 1 | 2 | 2010 | 97 | 0.170 |
Why?
|
Axons | 4 | 2010 | 1672 | 0.170 |
Why?
|
Nitric Oxide Donors | 1 | 2000 | 125 | 0.170 |
Why?
|
Electric Stimulation | 5 | 2010 | 1735 | 0.170 |
Why?
|
Basal Ganglia | 2 | 2013 | 552 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-fos | 4 | 2011 | 586 | 0.170 |
Why?
|
Calcitonin | 1 | 2020 | 330 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 854 | 0.170 |
Why?
|
Hot Temperature | 5 | 2017 | 1435 | 0.160 |
Why?
|
Neuroanatomical Tract-Tracing Techniques | 1 | 2019 | 40 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2003 | 359 | 0.160 |
Why?
|
Stress, Psychological | 1 | 2014 | 4446 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2000 | 329 | 0.160 |
Why?
|
Endocrine System | 1 | 2019 | 112 | 0.160 |
Why?
|
Rodentia | 1 | 2020 | 260 | 0.160 |
Why?
|
Dilatation | 1 | 2020 | 307 | 0.160 |
Why?
|
Time Factors | 13 | 2019 | 40139 | 0.160 |
Why?
|
Capsaicin | 2 | 2016 | 231 | 0.160 |
Why?
|
Vertigo | 1 | 2020 | 202 | 0.160 |
Why?
|
Muscle Contraction | 1 | 2023 | 1201 | 0.150 |
Why?
|
Wireless Technology | 1 | 2019 | 98 | 0.150 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22020 | 0.150 |
Why?
|
Hyperesthesia | 1 | 1998 | 23 | 0.150 |
Why?
|
Case-Control Studies | 7 | 2018 | 22052 | 0.150 |
Why?
|
Societies, Medical | 3 | 2024 | 3905 | 0.150 |
Why?
|
Pain Perception | 1 | 2019 | 196 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6498 | 0.150 |
Why?
|
Bradykinin | 1 | 1998 | 208 | 0.150 |
Why?
|
Dizziness | 1 | 2020 | 257 | 0.140 |
Why?
|
Mice | 8 | 2020 | 81209 | 0.140 |
Why?
|
Macrophage Activation | 1 | 2020 | 554 | 0.140 |
Why?
|
Mast Cells | 4 | 2011 | 1390 | 0.140 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2019 | 170 | 0.140 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2018 | 200 | 0.140 |
Why?
|
Cephaloridine | 1 | 2016 | 7 | 0.140 |
Why?
|
Receptors, Interleukin-1 Type II | 1 | 2016 | 11 | 0.140 |
Why?
|
Gene Expression | 2 | 2022 | 7587 | 0.140 |
Why?
|
Mustard Plant | 1 | 2016 | 14 | 0.140 |
Why?
|
Emotions | 2 | 2019 | 2734 | 0.130 |
Why?
|
Sensory System Agents | 1 | 2016 | 21 | 0.130 |
Why?
|
Mesencephalon | 1 | 2018 | 332 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 21 | 2021 | 36286 | 0.130 |
Why?
|
Anesthetics, Local | 2 | 2020 | 1001 | 0.130 |
Why?
|
Drug Synergism | 1 | 2020 | 1752 | 0.130 |
Why?
|
Prospective Studies | 6 | 2023 | 54306 | 0.130 |
Why?
|
Cranial Sutures | 1 | 2016 | 92 | 0.130 |
Why?
|
TRPC Cation Channels | 1 | 2016 | 110 | 0.130 |
Why?
|
Touch Perception | 1 | 2017 | 106 | 0.130 |
Why?
|
Viscera | 1 | 1996 | 138 | 0.130 |
Why?
|
Levodopa | 1 | 2016 | 217 | 0.130 |
Why?
|
Hypersensitivity | 2 | 2023 | 1155 | 0.130 |
Why?
|
Plant Oils | 1 | 2016 | 197 | 0.120 |
Why?
|
Glutamine | 2 | 2016 | 576 | 0.120 |
Why?
|
Dinoprostone | 1 | 1998 | 598 | 0.120 |
Why?
|
Potassium Chloride | 2 | 2010 | 230 | 0.120 |
Why?
|
Chronic Disease | 3 | 2020 | 9288 | 0.120 |
Why?
|
Cost of Illness | 1 | 2024 | 1940 | 0.120 |
Why?
|
Anatomy, Artistic | 1 | 2014 | 51 | 0.120 |
Why?
|
Sympathetic Nervous System | 1 | 2017 | 520 | 0.120 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2852 | 0.120 |
Why?
|
Triazoles | 2 | 2014 | 904 | 0.120 |
Why?
|
Biological Clocks | 1 | 2016 | 316 | 0.110 |
Why?
|
Gyrus Cinguli | 2 | 2021 | 1114 | 0.110 |
Why?
|
Cerebrospinal Fluid | 1 | 2017 | 544 | 0.110 |
Why?
|
Bayes Theorem | 1 | 2022 | 2326 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4899 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2009 | 4408 | 0.110 |
Why?
|
Nitric Oxide | 2 | 2019 | 2141 | 0.110 |
Why?
|
Aspartic Acid | 1 | 2016 | 576 | 0.110 |
Why?
|
Thermosensing | 1 | 1993 | 55 | 0.110 |
Why?
|
Sex Characteristics | 2 | 2015 | 2629 | 0.110 |
Why?
|
Hypothalamic Hormones | 1 | 2014 | 145 | 0.110 |
Why?
|
Skin Temperature | 1 | 1993 | 96 | 0.110 |
Why?
|
Brain Concussion | 2 | 2024 | 1394 | 0.110 |
Why?
|
Blood Vessels | 3 | 2009 | 1112 | 0.110 |
Why?
|
Pituitary Hormones | 1 | 2014 | 182 | 0.110 |
Why?
|
Glutamates | 1 | 2014 | 391 | 0.110 |
Why?
|
Vasopressins | 1 | 2014 | 355 | 0.110 |
Why?
|
Head | 1 | 1999 | 922 | 0.110 |
Why?
|
Isoflurane | 1 | 2016 | 384 | 0.110 |
Why?
|
Sleep Deprivation | 1 | 2019 | 840 | 0.110 |
Why?
|
Lectins, C-Type | 1 | 2016 | 587 | 0.100 |
Why?
|
Eating | 2 | 2014 | 1539 | 0.100 |
Why?
|
Melanins | 1 | 2014 | 291 | 0.100 |
Why?
|
Brain Waves | 1 | 2016 | 401 | 0.100 |
Why?
|
Locus Coeruleus | 1 | 2014 | 231 | 0.100 |
Why?
|
Injections | 3 | 2004 | 830 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1091 | 0.100 |
Why?
|
Norepinephrine | 1 | 2014 | 900 | 0.100 |
Why?
|
Ergotamine | 1 | 2011 | 7 | 0.100 |
Why?
|
Skin Diseases | 1 | 2000 | 1089 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25941 | 0.100 |
Why?
|
Depression | 2 | 2021 | 8045 | 0.090 |
Why?
|
Pulvinar | 1 | 2011 | 21 | 0.090 |
Why?
|
Neuronal Plasticity | 3 | 2015 | 1430 | 0.090 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2011 | 42 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2014 | 597 | 0.090 |
Why?
|
Aged | 15 | 2023 | 169143 | 0.090 |
Why?
|
Cohort Studies | 9 | 2023 | 41337 | 0.090 |
Why?
|
Oxytocin | 1 | 2014 | 401 | 0.090 |
Why?
|
Receptors, Immunologic | 1 | 2016 | 1414 | 0.090 |
Why?
|
Fasting | 1 | 2016 | 1603 | 0.090 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2009 | 23 | 0.080 |
Why?
|
Middle Cerebral Artery | 1 | 2011 | 276 | 0.080 |
Why?
|
Incidence | 2 | 2023 | 21391 | 0.080 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2011 | 281 | 0.080 |
Why?
|
Placebos | 1 | 2014 | 1668 | 0.080 |
Why?
|
Mastocytosis | 1 | 2011 | 149 | 0.080 |
Why?
|
Awareness | 1 | 2013 | 646 | 0.080 |
Why?
|
Mechanotransduction, Cellular | 1 | 2014 | 530 | 0.080 |
Why?
|
Medical Records | 1 | 2014 | 1407 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3426 | 0.080 |
Why?
|
Intracranial Pressure | 1 | 2011 | 325 | 0.080 |
Why?
|
Intermediate Filament Proteins | 1 | 2009 | 263 | 0.080 |
Why?
|
Nitrobenzenes | 1 | 2008 | 66 | 0.080 |
Why?
|
Neurologic Examination | 2 | 2015 | 916 | 0.080 |
Why?
|
Vasoconstriction | 1 | 2011 | 593 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1720 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2013 | 977 | 0.070 |
Why?
|
Rest | 3 | 2017 | 914 | 0.070 |
Why?
|
Prevalence | 3 | 2017 | 15686 | 0.070 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 687 | 0.070 |
Why?
|
Optic Nerve | 1 | 2011 | 567 | 0.070 |
Why?
|
Estrogens | 1 | 2014 | 1520 | 0.070 |
Why?
|
Dendrites | 1 | 2010 | 475 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2015 | 10826 | 0.070 |
Why?
|
Cyclooxygenase 2 | 1 | 2009 | 599 | 0.070 |
Why?
|
Cell Degranulation | 1 | 2007 | 276 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9530 | 0.070 |
Why?
|
Ion Channels | 1 | 2011 | 1043 | 0.070 |
Why?
|
Administration, Topical | 1 | 2008 | 697 | 0.070 |
Why?
|
Interleukin-1beta | 1 | 2011 | 999 | 0.060 |
Why?
|
Electrodes, Implanted | 1 | 2010 | 833 | 0.060 |
Why?
|
Amygdala | 1 | 1993 | 1351 | 0.060 |
Why?
|
Disabled Persons | 1 | 2015 | 1223 | 0.060 |
Why?
|
Infusions, Parenteral | 1 | 2005 | 399 | 0.060 |
Why?
|
Indomethacin | 1 | 2005 | 326 | 0.060 |
Why?
|
Electroencephalography | 1 | 2020 | 6189 | 0.060 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2024 | 20 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2021 | 8950 | 0.060 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 1 | 2024 | 36 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1431 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2873 | 0.060 |
Why?
|
Cromakalim | 1 | 2023 | 22 | 0.060 |
Why?
|
Child | 5 | 2024 | 79799 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3322 | 0.060 |
Why?
|
KATP Channels | 1 | 2023 | 48 | 0.060 |
Why?
|
Oxazolidinones | 1 | 2004 | 97 | 0.050 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2024 | 108 | 0.050 |
Why?
|
Mechanoreceptors | 2 | 2011 | 187 | 0.050 |
Why?
|
Low Back Pain | 1 | 2011 | 979 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2010 | 7850 | 0.050 |
Why?
|
Visual Perception | 1 | 2011 | 1374 | 0.050 |
Why?
|
Scalp | 1 | 2005 | 389 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2010 | 1688 | 0.050 |
Why?
|
Internet | 1 | 2014 | 3078 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9952 | 0.050 |
Why?
|
Oxygen | 2 | 2010 | 4193 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2003 | 471 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2011 | 3215 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4924 | 0.050 |
Why?
|
Recruitment, Neurophysiological | 1 | 2000 | 33 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6216 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9406 | 0.040 |
Why?
|
Neural Conduction | 2 | 2005 | 441 | 0.040 |
Why?
|
Sex Factors | 1 | 2014 | 10546 | 0.040 |
Why?
|
p-Methoxy-N-methylphenethylamine | 2 | 2011 | 41 | 0.040 |
Why?
|
Infusions, Intraventricular | 1 | 2019 | 32 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15840 | 0.040 |
Why?
|
Hippocampus | 1 | 2012 | 3738 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 2001 | 1900 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4356 | 0.040 |
Why?
|
Goals | 1 | 2024 | 708 | 0.040 |
Why?
|
Saline Solution, Hypertonic | 2 | 1996 | 114 | 0.040 |
Why?
|
Random Allocation | 1 | 2003 | 2394 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3709 | 0.040 |
Why?
|
Stress, Mechanical | 2 | 2007 | 1666 | 0.040 |
Why?
|
Sulfonamides | 1 | 2008 | 1977 | 0.040 |
Why?
|
Ergot Alkaloids | 1 | 2017 | 12 | 0.040 |
Why?
|
World Health Organization | 1 | 2024 | 1314 | 0.040 |
Why?
|
Autacoids | 1 | 1996 | 17 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1993 | 0.040 |
Why?
|
Spinothalamic Tracts | 1 | 1996 | 8 | 0.040 |
Why?
|
Community Health Planning | 1 | 2017 | 166 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8652 | 0.030 |
Why?
|
Efferent Pathways | 1 | 1996 | 165 | 0.030 |
Why?
|
Actigraphy | 1 | 2019 | 518 | 0.030 |
Why?
|
Research | 1 | 2024 | 1974 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 1996 | 660 | 0.030 |
Why?
|
Administration, Oral | 1 | 2004 | 4035 | 0.030 |
Why?
|
Spin Labels | 1 | 2017 | 336 | 0.030 |
Why?
|
MEDLINE | 1 | 2015 | 119 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11070 | 0.030 |
Why?
|
Functional Laterality | 2 | 2005 | 2253 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2017 | 80345 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2000 | 978 | 0.030 |
Why?
|
Thermoreceptors | 1 | 1993 | 27 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2221 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58980 | 0.030 |
Why?
|
Parahippocampal Gyrus | 1 | 2014 | 115 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14494 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2221 | 0.030 |
Why?
|
Enkephalins | 1 | 1994 | 139 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2025 | 0.030 |
Why?
|
Signal Transduction | 2 | 2023 | 23374 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2659 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2008 | 15286 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1994 | 575 | 0.030 |
Why?
|
Dexamethasone | 1 | 2020 | 1927 | 0.030 |
Why?
|
Cell Count | 1 | 1996 | 1835 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1996 | 2502 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2012 | 208 | 0.020 |
Why?
|
Motor Neurons | 1 | 1996 | 865 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1993 | 1705 | 0.020 |
Why?
|
Putamen | 1 | 2011 | 291 | 0.020 |
Why?
|
Public Health | 1 | 2023 | 2653 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2011 | 389 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 257 | 0.020 |
Why?
|
Protein Precursors | 1 | 1994 | 1134 | 0.020 |
Why?
|
Ectodysplasins | 1 | 2009 | 11 | 0.020 |
Why?
|
Touch | 1 | 2011 | 312 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2471 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8556 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 553 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2001 | 12762 | 0.020 |
Why?
|
Vimentin | 1 | 2009 | 255 | 0.020 |
Why?
|
Echo-Planar Imaging | 1 | 2012 | 657 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2010 | 2782 | 0.020 |
Why?
|
Cosmetic Techniques | 1 | 2010 | 148 | 0.020 |
Why?
|
Risk Factors | 2 | 2018 | 74333 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2005 | 20080 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6238 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18413 | 0.020 |
Why?
|
Dipeptides | 1 | 2009 | 410 | 0.020 |
Why?
|
Prostaglandin D2 | 1 | 2007 | 108 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7475 | 0.020 |
Why?
|
Leukotriene C4 | 1 | 2007 | 79 | 0.020 |
Why?
|
Cerebellum | 1 | 2014 | 1495 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2608 | 0.020 |
Why?
|
Stress, Physiological | 1 | 1994 | 1398 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13505 | 0.020 |
Why?
|
Epoprostenol | 1 | 2007 | 248 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 704 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 1994 | 11902 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1296 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2005 | 239 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3711 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1994 | 3734 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13312 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 616 | 0.010 |
Why?
|
Imidazoles | 1 | 2010 | 1180 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 2005 | 377 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16548 | 0.010 |
Why?
|
Blood Pressure | 1 | 1999 | 8525 | 0.010 |
Why?
|
United States | 2 | 2024 | 72448 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1180 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1490 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13308 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8458 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7408 | 0.010 |
Why?
|
Anesthesia | 1 | 2011 | 1584 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2011 | 2385 | 0.010 |
Why?
|
Pyrazoles | 1 | 2010 | 1999 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3725 | 0.010 |
Why?
|
Reaction Time | 1 | 2005 | 2075 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2696 | 0.010 |
Why?
|
Cognition | 1 | 2015 | 6964 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3539 | 0.010 |
Why?
|
Phosphorylation | 1 | 2007 | 8311 | 0.010 |
Why?
|
Supraoptic Nucleus | 1 | 1994 | 28 | 0.010 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 1994 | 114 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10553 | 0.010 |
Why?
|
Blood Volume | 1 | 1994 | 550 | 0.010 |
Why?
|
Cold Temperature | 1 | 1994 | 780 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1994 | 2262 | 0.010 |
Why?
|
Prognosis | 1 | 2008 | 29661 | 0.000 |
Why?
|